Kangho Suh is an Assistant Professor at the University of Pittsburgh School of Pharmacy, where he specializes in Health Economics & Outcomes Research within the Department of Pharmacy and Therapeutics. He joined the faculty in the fall of 2019 after he completed his PhD from The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington. Prior to his PhD training at The CHOICE Institute, he earned his PharmD from the Ernest Mario School of Pharmacy, Rutgers University and a MS in Pharmacy Administration at The University of Texas at Austin as part of the Novartis sponsored Health Economics & Outcomes Research post-doctoral fellowship.
Kangho's research interests lie at the intersection of health economics and pharmacoepidemiology. Specifically, he aims to advance patient care and advocate the use of value-based interventions through comparative effectiveness research, exploring heterogeneity of treatment effects, and building cost-effectiveness models. He has expertise using large secondary databases, including IBM® MarketScan®, and has constructed many budget impact and cost-effectiveness models for the pharmaceutical industry and Washington Research Foundation. Kangho is a member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and an external member of the Institute for Clinical and Economic Review (ICER) where he develops economic models.
Alkermes Pathways Research Award